Literature DB >> 1963714

Survival of smooth, rough and transposon mutant strains of Brucella abortus in bovine mammary macrophages.

R E Price1, J W Templeton, L G Adams.   

Abstract

Transposon mutants offer a unique way to evaluate the role of lipopolysaccharide (LPS) by producing a theoretical single-gene difference between the original strain and the transposon mutant strain. Comparative survival of Brucella abortus smooth strain 2308, rough RB51, smooth strain 19, and two transposon mutant strains (rough strain 2308::Tn5 Lac Z [m106] and rough strain 19::Tn5 Lac Z [m3], was tested in restrictive bovine mammary macrophages that were able to effectively reduce the percentage of intracellular bacterial survival and permissive bovine mammary macrophages that were unable to control the intracellular replication of B. abortus. The theoretical single-gene difference between strain 19 and strain 19::Tn5 lac Z [m3] and between smooth virulent strain 2308 and rough transposon mutant 2308::Tn5 lacZ [m106] is likely related to differences in LPS content or structure. Significant (P less than 0.05) reduction in the survival of rough strain 19::Tn5 Lac Z [m3] with no significant reduction in the rough transposon mutant strain 2308::Tn5 lacZ [m106] indicated that at least one factor other than LPS contributes to the intracellular survival of B. abortus in bovine macrophages.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963714     DOI: 10.1016/0165-2427(90)90119-d

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  9 in total

1.  Survival of a bacterioferritin deletion mutant of Brucella melitensis 16M in human monocyte-derived macrophages.

Authors:  P A Denoel; R M Crawford; M S Zygmunt; A Tibor; V E Weynants; F Godfroid; D L Hoover; J J Letesson
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments.

Authors:  J Pizarro-Cerdá; E Moreno; V Sanguedolce; J L Mege; J P Gorvel
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis.

Authors:  C M Fernandez-Prada; M Nikolich; R Vemulapalli; N Sriranganathan; S M Boyle; G G Schurig; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages.

Authors:  S M Jones; A J Winter
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

5.  Immune and pathologic responses in mice infected with Brucella abortus 19, RB51, or 2308.

Authors:  M G Stevens; S C Olsen; G W Pugh; M V Palmer
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages.

Authors:  F Godfroid; B Taminiau; I Danese; P Denoel; A Tibor; V Weynants; A Cloeckaert; J Godfroid; J J Letesson
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 7.  Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans.

Authors:  Jinkyung Ko; Gary A Splitter
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

8.  Interactions between Brucella melitensis and human phagocytes: bacterial surface O-Polysaccharide inhibits phagocytosis, bacterial killing, and subsequent host cell apoptosis.

Authors:  Carmen M Fernandez-Prada; Elzbieta B Zelazowska; Mikeljon Nikolich; Ted L Hadfield; R Martin Roop; Gregory L Robertson; David L Hoover
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 9.  Uncovering the Hidden Credentials of Brucella Virulence.

Authors:  R Martin Roop; Ian S Barton; Dariel Hopersberger; Daniel W Martin
Journal:  Microbiol Mol Biol Rev       Date:  2021-02-10       Impact factor: 11.056

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.